Mangalam Drugs & Organics Limited (NSE:MANGALAM)

India flag India · Delayed Price · Currency is INR
79.49
-0.24 (-0.30%)
May 30, 2025, 3:30 PM IST
-22.75%
Market Cap 1.25B
Revenue (ttm) 3.18B
Net Income (ttm) 67.21M
Shares Out n/a
EPS (ttm) 4.25
PE Ratio 18.61
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,395
Average Volume 33,273
Open 80.04
Previous Close 79.73
Day's Range 78.80 - 81.79
52-Week Range 70.10 - 144.99
Beta 0.13
RSI 49.83
Earnings Date May 30, 2025

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers API products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, ... [Read more]

Sector Healthcare
Founded 1972
Employees 432
Stock Exchange National Stock Exchange of India
Ticker Symbol MANGALAM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.